Ed Hernandez

Informational Hearings on Drug Prices Planned & Mylan CEO Invited to Participate

Today, in the final hours of the California State Legislative session, Senate Joint Resolution 29, authored by Senator Ed Hernandez (D-West Covina), was approved by the State Legislature and will be now sent to Washington, D.C. SJR 29 urges Congress to take action against the company Mylan, which makes the EpiPen.

Announces Series of Informational Hearings on Skyrocketing Drug Prices

In the final days of the California State Legislative session, Senator Ed Hernandez (D-West Covina) has introduced Senate Joint Resolution 29 (SJR 29), urging Congress to take action against the company Mylan, which manufactures the EpiPen.

SACRAMENTO – Today, Senator Ed Hernandez, O.D., (D-West Covina) has decided to stop moving SB 1010, one of the last remaining pieces of drug cost transparency legislation in the country.

“I introduced SB 1010 with the intention of shedding light on the reasons precipitating skyrocketing drug prices. The goal was transparency, making sure drug companies played by the same rules as everyone else in the healthcare industry.

High drug prices is a reason for increase

SACRAMENTO – Covered California announced a statewide weighted average increase of 13.2% for 2017, which is due in part to the loss of the federal reinsurance program and the high cost of specialty drugs.

Given Senator Ed Hernandez’ leadership as chair of the Senate Health Committee, he released the following statement:

SACRAMENTO – The Department of Toxic Substances Control (DTSC) recently added another violation to an already existing list of violations against Quemetco, Inc. The battery recycling facility in the City of Industry in Los Angeles County failed to maintain a functioning leak-detection system in its containment building that houses hazardous waste related to the facility’s handling of lead.

Senator Ed Hernandez (D-West Covina) released the following statement:

SB 1010 Now Heads to the Assembly Appropriations Committee

SACRAMENTO – Today, the Assembly Health Committee approved passage of Senate Bill 1010, which provides transparency in drug pricing.

Authored by Senator Ed Hernandez, O.D. (D-West Covina) and approved by a vote of 12-4, SB 1010 provides information on drug prices, a first step toward more affordable and accessible prescription drugs for Californians.

Fisher v. University of Texas case

SACRAMENTO – Senator Ed Hernandez (D-West Covina) released the following statement on the Supreme Court upholding the Fisher v. University of Texas case.

Ruling has potential to deny families access to healthcare

SACRAMENTO – Senator Ed Hernandez (D-West Covina), chair of the Senate Health Committee, released the following statement on the Supreme Court’s deadlocked ruling in the U.S. v. Texas case. California allows immigrants granted deferred action to receive comprehensive Medi-Cal coverage. With this ruling, families will no longer be eligible for comprehensive Medi-Cal coverage that they would have received under President Obama’s plan.

CalPERS & Sac Bee Support SB 1010

Assembly Health Committee Vote on Tuesday

SACRAMENTO – Support for drug cost transparency continues to grow as momentum builds for tomorrow’s Assembly Health Committee hearing on SB 1010, authored by Senator Ed Hernandez (D-West Covina).

SACRAMENTO – With the passage of the 2016-17 budget, the California Legislature made key investments to bolster higher education in the state.

Senator Ed Hernandez (D-West Covina) has been fighting to ensure California students have the necessary opportunities for advancement within the higher education system.